Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Pharmaco-genomics Pharmaco-metabolomics Pharmaco-transcriptomics Pharmaco-proteomics Search

Displaying entries 29826 - 29850 of 102031 in total

Drug	Drug Groups	Gene	Gene ID	Change	Interaction	Chromosome	References
							Clear
Decitabine	Approved Investigational	PXDC1	221749	upregulated	decitabine results in increased expression of PXDC1 mRNA	6p25.2	A20985
Decitabine	Approved Investigational	PYCARD	29108	upregulated	decitabine results in increased expression of PYCARD mRNA	16p11.2	A21919
Decitabine	Approved Investigational	QPCT	25797	upregulated	decitabine results in increased expression of QPCT mRNA	2p22.2	A21915
Decitabine	Approved Investigational	RAB13	5872	upregulated	decitabine results in increased expression of RAB13 mRNA	1q21.3	A20985
Decitabine	Approved Investigational	RAB5C	5878	upregulated	decitabine results in increased expression of RAB5C mRNA	17q21.2	A21917
Decitabine	Approved Investigational	RAB6C	84084	upregulated	decitabine results in increased expression of RAB6C mRNA	2q21.1	A22016
Decitabine	Approved Investigational	RAD17	5884	downregulated	decitabine results in decreased expression of RAD17 mRNA	5q13.2	A20985
Decitabine	Approved Investigational	RAG1	5896	upregulated	decitabine results in increased expression of RAG1 mRNA	11p12	A21915
Decitabine	Approved Investigational	RANGAP1	5905	upregulated	decitabine results in increased expression of RANGAP1 mRNA	22q13.2	A21917
Decitabine	Approved Investigational	RAP1GAP	5909	upregulated	decitabine results in increased expression of RAP1GAP mRNA	1p36.12	A22017
Decitabine	Approved Investigational	RAPGEFL1	51195	downregulated	decitabine results in decreased expression of RAPGEFL1 mRNA	17q21.1	A21913
Decitabine	Approved Investigational	RARB	5915	upregulated	decitabine results in increased expression of RARB mRNA	3p24.2	A22018 A22019 A21181
Decitabine	Approved Investigational	RARG	5916	upregulated	decitabine results in increased expression of RARG mRNA	12q13.13	A21917
Decitabine	Approved Investigational	RASSF1	11186	upregulated	decitabine results in increased expression of RASSF1 mRNA	3p21.31	A20778 A22020 A21931 A22021 A21963 A21933 A22022 A22023
Decitabine	Approved Investigational	RB1	5925	downregulated	decitabine results in decreased expression of RB1 mRNA	13q14.2	A21197
Decitabine	Approved Investigational	RBM34	23029	downregulated	decitabine results in decreased expression of RBM34 mRNA	1q42.3	A20985
Decitabine	Approved Investigational	RBP1	5947	upregulated	decitabine results in increased expression of RBP1 mRNA	3q23	A21919
Decitabine	Approved Investigational	RBP4	5950	upregulated	decitabine results in increased expression of RBP4 mRNA	10q23.33	A21919
Decitabine	Approved Investigational	RBP7	116362	upregulated	decitabine results in increased expression of RBP7 mRNA	1p36.22	A21935
Decitabine	Approved Investigational	RDX	5962	upregulated	decitabine results in increased expression of RDX mRNA	11q23	A20985
Decitabine	Approved Investigational	REC8	9985	upregulated	decitabine results in increased expression of REC8 mRNA	14q12	A21915
Decitabine	Approved Investigational	RECQL5	9400	downregulated	decitabine results in decreased expression of RECQL5 mRNA	17q25	A20985
Decitabine	Approved Investigational	REEP3	221035	downregulated	decitabine results in decreased expression of REEP3 mRNA	10q21.3	A21913
Decitabine	Approved Investigational	RELB	5971	upregulated	decitabine results in increased expression of RELB mRNA	19q13.32	A21930
Decitabine	Approved Investigational	RGS12	6002	upregulated	decitabine results in increased expression of RGS12 mRNA	4p16.3	A20985

Displaying entries 29826 - 29850 of 102031 in total

Pharmaco-transcriptomicsUp/down regulation of genes due to the metabolism of pharmaceutical compounds

Advanced Filter

Filter by Group

Filter by Market Availability